News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Santel Donald J
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/08/2023 |
4
| Santel Donald J (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns:
| Granted 12,500 options to buy
@ $16.3, valued at
$203.8k
|
|
01/23/2023 |
4
| Santel Donald J (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns:
| Granted 25,000 options to buy
@ $23.44, valued at
$586k
Granted 2,519 options to buy
@ $23.44, valued at
$59k
|
|
01/04/2023 |
4
| Santel Donald J (Director) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns:
| Unknown transaction of 5,489 shares
@ $0 Disposed/sold 8,198 shares
@ $0 Disposed/sold 15,170 options to buy
@ $14.25, valued at
$216.2k
Disposed/sold 5,359 options to buy
@ $3.63, valued at
$19.5k
|
|
06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/13/2021 |
4
| Santel Donald J (Former Director) has filed a Form 4 on Surrozen, Inc./DE
Txns:
| Granted 30,000 shares
@ $0 Disposed/sold 30,000 options to buy
@ $0 |
|
08/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/05/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|